Skip to main content

Chemotherapy

Online First
Feasibility of Supplemental Materials Alongside Pharmacist-Led Chemotherapy Education: A Prospective Pilot Study
Neha Betrabet, PharmD, BCOP; Sabrina Cannon, PharmD, BCOP; Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA; Vincent Cascone, PharmD, BCO
Read More
Online First
Impact of Pharmacist-Driven Oral Chemotherapy Treatment Plan Implementation on Monitoring and Supportive Care Interventions During CDK4/6 Inhibitor Therapy for Patients With Breast Cancer
Morgan Felitte, PharmD; Hannah Kisla, PharmD, BCOP; Elizabeth Brady, PharmD, CSP; Darlene Tat, PharmD, MPH; Jessica Mills, PharmD; Jennifer McDonald, PharmD, BCPS
Read More
Online First
Characterization of A Dose-Dense Doxorubicin and Cyclophosphamide Regimen for Triple-Negative Breast Cancer Within the KEYNOTE-522 Trial
Samantha Hodges, PharmD; Katelyn Patterson, PharmD; Vera Ljucovic, PharmD
Read More
Online First
Risk for Vincristine-Induced Adverse Events With Aprepitant in Pediatric Patients With Rhabdomyosarcoma
Kallie Erickson Varughese, PharmD, BCPPS; M. Brooke Bernhardt, PharmD, MS; Tiffany M. Chambers, MPH; Jennifer H. Foster, MD, MPH; Holly B. Lindsay, MD, MS; Philip J. Lupo, PhD, MPH; Hannah E. Sauer, PharmD, BCOP
Read More
Online First
Implementation of a Cardio-Oncology Pharmacist Position in a Community Cancer Center
Marcela W. Heiss, PharmD, BCOP; Robert Mancini, PharmD, BCOP, FHOPA; Chase Ayres, PharmD, BCOP
Read More
Online First
Evaluation of Bleeding Events in Patients Who Received Ibrutinib With or Without Antithrombotic Therapy
Frank A. Lattuca, PharmD, BCOP; Jeremiah E. Moore, PharmD, BCOP; Carissa Treptow, PharmD, BCOP; Kendra Delibert, PharmD, BCOP; Andrea Baran, MS; Clive S. Zent, MD
Read More
Online First
Highly Effective Treatment for Bone-Only Signet Ring Cell Breast Cancer With Ribociclib, Fulvestrant, and Denosumab: A Case Study
Marjorie Ford Nenadich, PharmD, BS; Michelle Faith Nenadich, BSN; Basel Shoua, MD
Read More
Evaluation of Outcomes and Adverse Events of a Hypomethylating Agent Plus Venetoclax Versus 7+3 Induction Chemotherapy in Patients Aged 50 to 70 Years
Robin Tumlinson, PharmD; Erin Kennedy, PharmD, BCOP; Alice Parish, MSPH; Alaattin Erkanli, PhD
Read More
Online First
Irinotecan-Induced Hypertonia: A Case Report
Vallabhi Mishra, PharmD; Krutika Gohil, MBBS; Alyssa Tian Gu, BS Candidate; Alexandra Zhikharev, BS Candidate; Minaxi Jhawer, MD
Read More
Online First
Financial Effect of Automated Chemotherapy Dose Rounding at an Academic Medical Center
Keeyan Davis, PharmD; Junyu Matt Zhang, PharmD, BCOP, BCPS; Katherine Moser, PharmD, BCPS
Read More
Page 1 of 5
Results 1 - 10 of 50